Scientists at the University of Alberta have discovered that important risk factors in Alzheimer’s disease affect males and females very differently.
One in nine Americans ages 65 and over had Alzheimer’s disease in 2022, and countless others were indirectly affected as caregivers, health care providers and…
Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition—and treatment options are limited.
Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases. An…
Mice exposed to World Trade Center dust exhibit a significant impairment in spatial recognition and short- and long-term memory, as well as changes in genes…
Choline, an essential nutrient produced in small amounts in the liver and found in foods including eggs, broccoli, beans, meat and poultry, is a vital…
A leading Swansea University scientist has developed a new “smart patch” that can detect proinflammatory biomarkers of neurodegenerative diseases (such as Parkinson’s and Alzheimer’s) through…
The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway”…
Hormone Replacement Therapy (HRT) could help prevent Alzheimer’s Dementia among women at risk of developing the disease—according to University of East Anglia research.
University of Virginia neuroscientists have revealed how a toxic form of tau protein, notorious for forming tangles in the brains of people with Alzheimer’s disease…